ArticleMolecular therapy : the journal of the American Society of Gene Therapy2022

Identification of FDA-approved bifonazole as a SARS-CoV-2 blocking agent following a bioreporter drug screen.

Zaid Taha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.